Skip to content
Search

Latest Stories

Labour's collaboration with Virgin Media O2 to empower children with Type 1 Diabetes

Labour's collaboration with Virgin Media O2 to empower children with Type 1 Diabetes
The Labour's collaboration with Virgin Media O2 and SCD to improve healthcare access and outcomes for 32,000 children in the UK living with type 1 diabetes

In an announcement following Keir Starmer's  and Wes Streeting's visit to a hospital in the East Midlands, Labour Party has unveiled a groundbreaking partnership with Virgin Media O2 aimed at ensuring every child with type 1 diabetes can access the latest medical technology to better manage diabetes.

With the NHS providing patients with type 1 diabetes the option of an 'artificial pancreas' in the next five years to manage insulin levels and Continuous Glucose Monitors launched nearly 2 years ago to monitor children’s glucose levels, the initiative aims to address the financial barrier hindering hundreds of families from benefiting from this breakthrough.


Labour's plan to provide every child in need a smartphone, facilitating access to modern glucose monitors, aligns with the centre-leftist party's broader vision to harness technology for healthcare transformation.

Announcing the partnership in an interview with ITV News, Keir Starmer, Labour Party Leader, highlighted the lack of equitable access to medical advancement amongst patients as "travesty" and "impact of fourteen years of Conservative chaos has had on the NHS",  stating:

"Our ten-year plan for change and modernization of the NHS will bring our analogue service into the digital age. We will secure the benefits of the revolution in medical technology for all."

Wes Streeting MP, Labour’s Shadow Health Secretary, who recently criticised the Tories as the reason for "Britain's decline" , underscored the urgency of leveraging modern technology to enhance patient care and bridge healthcare disparities.

Warning that under the Tories, the NHS is failing to harness the benefits of AI and new treatments, Streeting said, "If this continues, the two-tier healthcare system that is emerging in our country today will grow, the gap between public and private widen, and the NHS will become the poor man’s service. That is the future we must avoid."

Virgin Media O2 has pledged to donate recycled devices free of charge, reducing the hassle and stress for those families affected by diabetes, by making it faster and easy to monitor blood glucose levels.

Nicola Green, Corporate Affairs Director of Virgin Media O2, highlighted the importance of digital technology in managing diabetes and commended Labour's initiative.

Carolyn Goldhill, Founder and CEO of Supporting Children with Diabetes (SCD), also expressed delight over the partnership, emphasizing the critical role smartphones play in getting rid of the "constant finger pricking to test blood sugar" facilitating remote monitoring for children with type 1 diabetes.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less